| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/26/2011 | US20110124681 Topical and injectable formulations comprising leukotriene receptor antagonist and uses thereof |
| 05/26/2011 | US20110124680 Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors |
| 05/26/2011 | US20110124679 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
| 05/26/2011 | US20110124678 Treatment with alpha 7-selective ligands |
| 05/26/2011 | US20110124677 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 05/26/2011 | US20110124676 Biaryl substituted azabicyclic alkane derivatives |
| 05/26/2011 | US20110124675 The hydrosulfate of prasugrel, its pharmaceutical combination and use thereof |
| 05/26/2011 | US20110124674 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 05/26/2011 | US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 05/26/2011 | US20110124672 Thienyl Compounds |
| 05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
| 05/26/2011 | US20110124670 Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis |
| 05/26/2011 | US20110124669 Modulators of Cellular Adhesion |
| 05/26/2011 | US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 05/26/2011 | US20110124667 Methods for the treatment of irritable bowel syndrome |
| 05/26/2011 | US20110124666 3,4-dihydropyrimidine trpa1 antagonists |
| 05/26/2011 | US20110124665 Novel, Cyclically Substituted Furopyrimidine Derivatives and Use Thereof |
| 05/26/2011 | US20110124664 Polycationic Compounds And Uses Thereof |
| 05/26/2011 | US20110124663 Substituted dioxopiperidines and dioxopyrrolidines as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 05/26/2011 | US20110124662 Substituted Carbamate Derivatives as Modulators of Corticotropin-Releasing Factor Receptor Activity |
| 05/26/2011 | US20110124661 Oxazolobenzimidazole derivatives |
| 05/26/2011 | US20110124659 Cycloalkane derivative |
| 05/26/2011 | US20110124658 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 05/26/2011 | US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
| 05/26/2011 | US20110124656 Methods and Compositions for Treating Symptoms Associated with Post-Traumatic Stress Disorder using Cyclobenzaprine |
| 05/26/2011 | US20110124655 Kmup-1 capable of treating hypertension |
| 05/26/2011 | US20110124654 Diazacarbazoles and methods of use |
| 05/26/2011 | US20110124653 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 05/26/2011 | US20110124652 Chemical Compounds and Uses |
| 05/26/2011 | US20110124650 Stable crystalline salts of antifolate compounds |
| 05/26/2011 | US20110124649 Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders |
| 05/26/2011 | US20110124648 Glucagon receptor antagonists, preparation and therapeutic uses |
| 05/26/2011 | US20110124646 Novel cyclic compound having pyrimidinylalkylthio group |
| 05/26/2011 | US20110124645 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 05/26/2011 | US20110124644 Methods of diagnosing and characterizing cannabinoid signaling in crohn's disease |
| 05/26/2011 | US20110124643 Pyridinopyridinone derivatives, preparation thereof and therapeutic use thereof |
| 05/26/2011 | US20110124642 Potassium channel modulators |
| 05/26/2011 | US20110124641 Benzothiazole kinase inhibitors and methods of use |
| 05/26/2011 | US20110124640 Fused heterocyclic compounds useful as kinase modulators |
| 05/26/2011 | US20110124639 3 beta-hydroxysteroid dehydrogenase inhibitors |
| 05/26/2011 | US20110124638 Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors |
| 05/26/2011 | US20110124637 Benzimidazoles and related analogs as sirtuin modulators |
| 05/26/2011 | US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 05/26/2011 | US20110124635 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 05/26/2011 | US20110124634 Bioactive compounds for treatment of cancer and neurodegenerative diseases |
| 05/26/2011 | US20110124633 Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy |
| 05/26/2011 | US20110124632 Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition |
| 05/26/2011 | US20110124631 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors |
| 05/26/2011 | US20110124630 Stemonamide synthesis intermediate and pharmaceutical composition for prevention and/or treatment of cancer |
| 05/26/2011 | US20110124629 Crystalline Forms of a Pharmaceutical Compound |
| 05/26/2011 | US20110124628 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 05/26/2011 | US20110124627 Modulators of toll-like receptors |
| 05/26/2011 | US20110124626 Benzazepine derivatives and their use as histamine h3 antagonists |
| 05/26/2011 | US20110124625 Modulators of Cellular Adhesion |
| 05/26/2011 | US20110124624 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124623 Pyrrolotriazine kinase inhibitors |
| 05/26/2011 | US20110124622 Isoindolones derivatives as mek kinase inhibitors and methods of use |
| 05/26/2011 | US20110124621 Benzothiazoles as ghrelin receptor modulators |
| 05/26/2011 | US20110124620 Sphingosine 1 phosphate receptor moduators and their use to treat muscle inflammation |
| 05/26/2011 | US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 05/26/2011 | US20110124618 Substituted (pyrazolylcarbonyl)imidazolidinones and their use |
| 05/26/2011 | US20110124617 Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent |
| 05/26/2011 | US20110124616 Method for treating retinal conditions using an intraocular tamponade |
| 05/26/2011 | US20110124615 Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 05/26/2011 | US20110124614 Methods And Compositions For The Treatment of Autoimmune Disorders |
| 05/26/2011 | US20110124613 Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma |
| 05/26/2011 | US20110124612 Multi-phase contraceptive preparation based on a natural estrogen |
| 05/26/2011 | US20110124611 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 05/26/2011 | US20110124610 Method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k |
| 05/26/2011 | US20110124609 Method of Preventing Type I Diabetes |
| 05/26/2011 | US20110124608 Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals |
| 05/26/2011 | US20110124607 Composition for regulation cellular senescence comprising lysophosphatidic acid and inhibitor of adenylyl cyclase as active ingredients |
| 05/26/2011 | US20110124606 Sense-improving agent |
| 05/26/2011 | US20110124605 Use of an S1P Receptor Agonist |
| 05/26/2011 | US20110124604 Phospholipid receptors as targets for enhancing drug permeability to selected tissues |
| 05/26/2011 | US20110124603 Trioxane Dimer Sulfur Compounds |
| 05/26/2011 | US20110124602 Stat3 Inhibitor Having Anti-Cancer Activity and Methods |
| 05/26/2011 | US20110124601 Aminophosphinic derivatives that can be used in the treatment of pain |
| 05/26/2011 | US20110124600 Use of Dopamine partial agonists for treament of the restless leg syndrome and corresponding pharmaceutical preparation |
| 05/26/2011 | US20110124599 2,4-Pyrimidinediamine Compounds and Prodrugs and Their Uses |
| 05/26/2011 | US20110124598 Chemical compounds |
| 05/26/2011 | US20110124597 Boron containing small molecules |
| 05/26/2011 | US20110124596 Composition for treating inflammatory diseases |
| 05/26/2011 | US20110124594 Compositions that aim to promote the development and growth of a beneficial vaginal microflora |
| 05/26/2011 | US20110124593 Methods for determining chemotherapeutic agents targeting alpha-glucan pathways and uses thereof |
| 05/26/2011 | US20110124592 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitus c virus |
| 05/26/2011 | US20110124591 Compounds and methods for modulating protein expression |
| 05/26/2011 | US20110124590 Oil-in-Water Emulsion Comprising Solvent, Water, Surfactant and Pesticide |
| 05/26/2011 | US20110124589 Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
| 05/26/2011 | US20110124587 Pure Rebaudioside A |
| 05/26/2011 | US20110124585 Dimeric Small Molecule Potentiators of Apoptosis |
| 05/26/2011 | US20110124584 Compositions and methods for treating diseases |
| 05/26/2011 | US20110124580 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/26/2011 | US20110124579 Sialic acid to support salivation |
| 05/26/2011 | US20110124577 Preparation for oral administration comprises quercetin glycoside and a water-based solvent extract of cartilage containing chondroitin sulfate |
| 05/26/2011 | US20110124573 Osmoprotective Complexes for Prevention of Intra-cellular Dehydration in Mammals |
| 05/26/2011 | US20110124567 Therapeutic compounds and methods |
| 05/26/2011 | US20110124565 Modified Coagulation Factor VIII With Enhanced Stability and Its Derivatives |
| 05/26/2011 | US20110124559 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/26/2011 | US20110124558 Novel uses of d-mannopyranose derivatives activating angiogenesis |